Latest updates for Pfe
Fresh curated links around PFE are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Pfizer-backed Priovant wins FDA approval for lead asset
- FENI: Developed Markets ETF With A Fundamental Edge
- Pfizer: Still Cheap Valuation Meets A Looming Patent Cliff
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
seekingalpha.com
/3 weeks ago
Pfizer: Still Cheap Valuation Meets A Looming Patent Cliff
fool.com
/2 weeks ago
Prediction: This Is Where Pfizer Stock Will Be in 2030
Pfizer is facing material patent expirations over the next two years, but that will be over by 2030.
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Pfe
seekingalpha.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
fool.com
Recent coverage from public sources
Public source